OMRON Corporation

OMRNY

Industrial - Machinery · Industrials

Price

$40.95

+0.08 (+0.20%)

Market Cap

$8.05B

Exchange

Other OTC

Winston Score

Winston is curious

Mixed quality — meaningful strengths and weaknesses.

Data as of Aug 29, 2026 · filings through Jun 30, 2026

How the score breaks down

Quality

Mixed

Growth

Mixed

Cash Flow

Strong

Stability

Exceptional

Valuation

Good

Dividends

Weak

Track this stock — start free trial

Share count falling — buybacks

−2.1% over 4y

The company has reduced its share count over this period, returning value to shareholders through buybacks.

Diluted shares outstanding: 200.9M (2022) → 196.7M (2026)

Winston Score History

The full picture

OMRON is a Japanese electronics and automation company that makes sensors, controllers, robots, and other equipment used in factories to help machines run automatically. It also produces healthcare devices like blood pressure monitors and thermometers that people use at home. The company is one of the world's leading makers of industrial automation components and a top brand in home health monitoring devices.

OMRON earns revenue by selling hardware components and systems to manufacturers across industries like automotive, electronics, and food production, as well as consumer health products sold globally. Headquartered in Kyoto, Japan, it operates in over 120 countries with a market cap around $8 billion. Its broad product lineup and deep expertise in sensing and control technology give it a strong position in factory automation. Growth depends on increasing demand for automation as labor shortages spread worldwide, but the business faces risk from cyclical slowdowns in industrial spending, particularly in China.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale

Gross Margin

46.5%

Healthy — 46.5% gross margin

Profit after running costs

Operating Margin

9.4%

Modest — 9.4% operating margin

Return on the money invested

ROCE

7.0%

Weak — 7.0% return on capital

ROIC between 5% and 15%. They earn 5 to 15 cents back per year on every dollar invested.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth

Sales YoY

-0.8%

Shrinking sales (-0.8% YoY)

Profit growth

EPS YoY

+0.7%

Flat earnings

Single-digit earnings growth — steady but not exciting.

How steady the profit is

EPS Consistency

6/8 quarters

Earnings grew in most of the last 8 quarters

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash

Cash Conversion

346%

Turns 346% of profit into real cash

Spare cash per sale

FCF Margin

8.0%

Modest free cash flow (8.0%)

FCF margin between 0% and 10%. Some cash from sales, but not a lot.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns

Debt / Equity

0.29

Conservative — low debt load (0.29)

Covers its interest

Interest Cover

58.52x

Comfortably covers interest (58.5x)

Interest coverage above 8. Profits cover interest many times over.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit

P/E Ratio (TTM)

40.4x

Pricey — P/E 40.4

P/E over 35. The market is pricing in heavy, sustained growth.

Cheaper or dearer next year

P/E vs Forward

+22.0

GROWING

Earnings expected to grow meaningfully — cheaper on forward P/E (40.4 → 18.3)

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Dividend

Dividend Yield

0.01%

Small dividend — 0.01% yield

Modest yield. The bulk of any return needs to come from price appreciation.

Dividend record

Dividend Growth

-28.9%

Dividend cut (-28.9% YoY) — warning sign

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.

Start free trial